Kyushu University Academic Staff Educational and Research Activities Database
List of Reports
Hideya Onishi Last modified dateļ¼š2023.11.22

Associate Professor / Department of Cancer Therapy and Research / Department of Advanced Medical Initiatives / Faculty of Medical Sciences

1. Morisaki T, Morisaki T, Kubo M, Morisaki S, Nakamura Y, Onishi H, Lymph nodes as anti-tumor immunotherapeutic tool: intranodal tumor-specific antigen-pulsed dendritic cell vaccine immunotherapy, Cancers, 10.3390/cancers14102438, 2022.05.
2. Onishi H, Nakamura K, Yanai K, Nagai S, Nakayama K, Oyama Y, Fujimura A, Ozono K, Yamasaki A, Cancer therapy that targets the HEDGEHOG signaling pathway considering the cancer microenvironment, Oncol Rep 47(5): 93, 10.3892/or.2022.8304, 2022.05.
3. Yamasaki A, Yanai K, Onishi H, Hypoxia and pancreatic ductal adenocarcinoma., Cancer Lett, doi: 10.1016/j.canlet.2020.04.018, 2020.08.
4. Hideya Onishi, Mitsuo Katano, Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer., World J Gastroenterol, 2014.03.
5. Morisaki T, Onishi H, Katano M. , Cancer immunotherapy using NKG2D and DNAM-1 systems. , Anticancer Res, 2012.06.
6. Onishi H, Katano M, Immunotherapy approaches targeting regulatory T-cells, Anticancer Res, 2012.03.
7. Onishi H and Katano M, Hedgehog signaling pathway as a therapeutic target in various types of cancer., Cancer Science, 2011.10.
8. Onishi H, Morisaki T, Baba E, Nakamura M, Inaba S, Kuroki H, Matsumoto K, Katano M, Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma., Anticancer Res, 2011.11.
9. Onishi H, Morisaki T, Kuga H, Katano M, Doi F, Uchiyama A, Sugitani A, Wada J, Chijiiwa K, Tanaka M. , A large quantity of CD3-/CD19-/CD16- lymphocytes in malignant pleural effusion from a patient with recurrent cholangio cell carcinoma.

, Immunol Invest. 2002 May;31(2):121-35., 2006.06.
10. Morisaki T, Matsumoto K, Onishi H, Kuroki H, Baba E, Tasaki A, Kubo M, Nakamura M, Inaba S, Yamaguchi K, Tanaka M, Katano M. , Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives.

, Hum Cell. 2003 Dec;16(4):175-82, 2003.12.
11. Onishi H, Morisaki T, Nakafusa Y, Nakashima Y, Yokohata K, Katano M., Objective response with lapatinib in patients with meningitis carcinomatosa derived from HER2/HER1-negative breast cancer., Int J Clin Oncol , 2011.05.
12. Ohnishi H,Nishihara K,Tamae K,Mitsuyama S,Abe R,Toyoshima S,Abe E, Granular cell tumors of the breast: A report of two cases., Surg. Today, 26:929-932, 1996.04.